Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Diagnosis and outcome of resected solitary pulmonary nodules after liver transplantation.

Tone M, Awano N, Izumo T, Yoshimura H, Jo T, Kuse N, Inomata M, Fukumoto K, Furuhata Y, Hashimoto T, Kumasaka T, Kunitoh H.

Jpn J Clin Oncol. 2019 Nov 5. pii: hyz159. doi: 10.1093/jjco/hyz159. [Epub ahead of print]

PMID:
31688936
2.

Treatment effect and safety profile of salvage chemotherapy following immune checkpoint inhibitors in lung cancer.

Tone M, Izumo T, Awano N, Kuse N, Inomata M, Jo T, Yoshimura H, Miyamoto S, Kunitoh H.

Lung Cancer Manag. 2019 May 9;4(6):LMT12. doi: 10.2217/lmt-2019-0001. eCollection 2019 Oct.

3.

High mortality and poor treatment efficacy of immune checkpoint inhibitors in patients with severe grade checkpoint inhibitor pneumonitis in non-small cell lung cancer.

Tone M, Izumo T, Awano N, Kuse N, Inomata M, Jo T, Yoshimura H, Minami J, Takada K, Miyamoto S, Kunitoh H.

Thorac Cancer. 2019 Oct;10(10):2006-2012. doi: 10.1111/1759-7714.13187. Epub 2019 Sep 3.

4.

Impact of preoperative pathological confirmation on surgical and postoperative outcomes of lung resection for early stage lung cancer.

Izumo T, Terada Y, Inomata M, Kuse N, Awano N, Tone M, Jo T, Yoshimura H, Moriya A, Furuhata Y.

Adv Respir Med. 2019;87(4):203-208. doi: 10.5603/ARM.a2019.0034.

5.

Issues associated with medical tourism for cancer care in Japan.

Awano N, Takamoto T, Kawakami J, Genda A, Ninomiya A, Ikeda M, Matsuno F, Izumo T, Kunitoh H.

Jpn J Clin Oncol. 2019 Aug 1;49(8):708-713. doi: 10.1093/jjco/hyz061.

PMID:
31329917
6.

Catalase expression of Propionibacterium acnes may contribute to intracellular persistence of the bacterium in sinus macrophages of lymph nodes affected by sarcoidosis.

Yamamoto K, Uchida K, Furukawa A, Tamura T, Ishige Y, Negi M, Kobayashi D, Ito T, Kakegawa T, Hebisawa A, Awano N, Takemura T, Amano T, Akashi T, Eishi Y.

Immunol Res. 2019 Jun;67(2-3):182-193. doi: 10.1007/s12026-019-09077-9.

PMID:
31187451
7.

Diagnostic utility of transbronchial lung cryobiopsy: Two cases of anti-aminoacyl-tRNA synthetase syndrome with respiratory failure.

Yoshimura H, Awano N, Inomata M, Kuse N, Tone M, Jo T, Takemura T, Kumasaka T, Izumo T.

Respir Investig. 2019 Jul;57(4):399-403. doi: 10.1016/j.resinv.2019.03.002. Epub 2019 May 1.

PMID:
31054836
8.

Rapid effects of benralizumab on severe asthma during surgery for residual tumor after advanced lung squamous cell carcinoma treatment with pembrolizumab.

Izumo T, Terada Y, Tone M, Inomata M, Kuse N, Awano N, Moriya A, Jo T, Yoshimura H, Furuhata Y.

Respir Med Case Rep. 2019 Feb 19;26:292-295. doi: 10.1016/j.rmcr.2019.02.015. eCollection 2019.

9.

Management and utility of transbronchial lung cryobiopsy in Japan.

Kuse N, Inomata M, Awano N, Yoshimura H, Jo T, Tone M, Moriya A, Bae Y, Kumasaka T, Takemura T, Izumo T.

Respir Investig. 2019 May;57(3):245-251. doi: 10.1016/j.resinv.2018.12.011. Epub 2019 Feb 10.

PMID:
30745273
10.

Nivolumab and stereotactic radiation therapy for the treatment of patients with Stage IV non-small-cell lung cancer.

Miyamoto S, Nomura R, Sato K, Awano N, Kuse N, Inomata M, Izumo T, Terada Y, Furuhata Y, Bae Y, Kunitoh H.

Jpn J Clin Oncol. 2019 Feb 1;49(2):160-164. doi: 10.1093/jjco/hyy171.

PMID:
30452687
11.

The combination of EBUS-TBNA and the PAB antibody led to a successful treatment for lung cancer in a patient with asymptomatic sarcoidosis mimicking nodal metastasis.

Tone M, Awano N, Inomata M, Kuse N, Jo T, Yoshimura H, Furuhata Y, Takemura T, Kumasaka T, Izumo T.

Respir Med Case Rep. 2018 Oct 18;25:296-299. doi: 10.1016/j.rmcr.2018.10.014. eCollection 2018.

12.

The Significant Antitumor Activity of Nivolumab in Lung Adenocarcinoma with Choriocarcinomatous Features.

Ochi M, Miyamoto S, Terada Y, Furuhata Y, Awano N, Izumo T, Ikushima S, Bae Y, Kumasaka T, Kunito H.

Intern Med. 2018 Jun 15;57(12):1773-1777. doi: 10.2169/internalmedicine.0002-17. Epub 2018 Feb 9.

13.

Propionibacterium acnes-derived insoluble immune complexes in sinus macrophages of lymph nodes affected by sarcoidosis.

Suzuki Y, Uchida K, Takemura T, Sekine M, Tamura T, Furukawa A, Hebisawa A, Sakakibara Y, Awano N, Amano T, Kobayashi D, Negi M, Kakegawa T, Wada Y, Ito T, Suzuki T, Akashi T, Eishi Y.

PLoS One. 2018 Feb 5;13(2):e0192408. doi: 10.1371/journal.pone.0192408. eCollection 2018.

14.

Is hypothyroidism in idiopathic pleuroparenchymal fibroelastosis a novel lung-thyroid syndrome?

Awano N, Izumo T, Fukuda K, Tone M, Yamada D, Takemura T, Ikushima S, Kumasaka T.

Respir Investig. 2018 Jan;56(1):48-56. doi: 10.1016/j.resinv.2017.08.010. Epub 2017 Oct 7.

PMID:
29325681
15.

Efficacy and safety of stereotactic body radiotherapy using CyberKnife in Stage I primary lung tumor.

Awano N, Ikushima S, Izumo T, Tone M, Fukuda K, Miyamoto S, Bae Y, Kumasaka T, Terada Y, Furuhata Y, Nomura R, Sato K.

Jpn J Clin Oncol. 2017 Oct 1;47(10):969-975. doi: 10.1093/jjco/hyx100.

PMID:
28981731
16.

Histological analysis of vasculopathy associated with pulmonary hypertension in combined pulmonary fibrosis and emphysema: comparison with idiopathic pulmonary fibrosis or emphysema alone.

Awano N, Inomata M, Ikushima S, Yamada D, Hotta M, Tsukuda S, Kumasaka T, Takemura T, Eishi Y.

Histopathology. 2017 May;70(6):896-905. doi: 10.1111/his.13153. Epub 2017 Feb 8.

PMID:
27992963
17.

Influenza virus infection causes neutrophil dysfunction through reduced G-CSF production and an increased risk of secondary bacteria infection in the lung.

Ishikawa H, Fukui T, Ino S, Sasaki H, Awano N, Kohda C, Tanaka K.

Virology. 2016 Dec;499:23-29. doi: 10.1016/j.virol.2016.08.025. Epub 2016 Sep 12.

18.

Sarcoid Myositis with Anti-Ku Antibody Consistent with both Sarcoidosis and Polymyositis.

Awano N, Fukuda K, Sakayori M, Kondoh K, Ono R, Moriya A, Ando T, Kumasaka T, Takemura T, Ikushima S.

Intern Med. 2016;55(15):2049-53. doi: 10.2169/internalmedicine.55.5816. Epub 2016 Aug 1.

19.

Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.

Masaki Y, Kawabata H, Takai K, Kojima M, Tsukamoto N, Ishigaki Y, Kurose N, Ide M, Murakami J, Nara K, Yamamoto H, Ozawa Y, Takahashi H, Miura K, Miyauchi T, Yoshida S, Momoi A, Awano N, Ikushima S, Ohta Y, Furuta N, Fujimoto S, Kawanami H, Sakai T, Kawanami T, Fujita Y, Fukushima T, Nakamura S, Kinoshita T, Aoki S.

Int J Hematol. 2016 Jun;103(6):686-92. doi: 10.1007/s12185-016-1979-1. Epub 2016 Mar 18.

PMID:
27084250
20.

ydfD encodes a novel lytic protein in Escherichia coli.

Masuda H, Awano N, Inouye M.

FEMS Microbiol Lett. 2016 Mar;363(6). pii: fnw039. doi: 10.1093/femsle/fnw039. Epub 2016 Feb 16.

21.

Transformation to small-cell lung cancer as a mechanism of acquired resistance to crizotinib and alectinib.

Miyamoto S, Ikushima S, Ono R, Awano N, Kondo K, Furuhata Y, Fukumoto K, Kumasaka T.

Jpn J Clin Oncol. 2016 Feb;46(2):170-3. doi: 10.1093/jjco/hyv173. Epub 2015 Nov 27.

PMID:
26613679
22.

Trousseau's syndrome: cancer-associated thrombosis.

Ikushima S, Ono R, Fukuda K, Sakayori M, Awano N, Kondo K.

Jpn J Clin Oncol. 2016 Mar;46(3):204-8. doi: 10.1093/jjco/hyv165. Epub 2015 Nov 6. Review.

PMID:
26546690
23.

Propionibacterium acnes catalase induces increased Th1 immune response in sarcoidosis patients.

Yorozu P, Furukawa A, Uchida K, Akashi T, Kakegawa T, Ogawa T, Minami J, Suzuki Y, Awano N, Furusawa H, Miyazaki Y, Inase N, Eishi Y.

Respir Investig. 2015 Jul;53(4):161-9. doi: 10.1016/j.resinv.2015.02.005. Epub 2015 May 23.

PMID:
26100176
24.

An autopsy study of combined pulmonary fibrosis and emphysema: correlations among clinical, radiological, and pathological features.

Inomata M, Ikushima S, Awano N, Kondoh K, Satake K, Masuo M, Kusunoki Y, Moriya A, Kamiya H, Ando T, Yanagawa N, Kumasaka T, Ogura T, Sakai F, Azuma A, Gemma A, Takemura T.

BMC Pulm Med. 2014 Jun 28;14:104. doi: 10.1186/1471-2466-14-104.

25.

Transcriptional repressor HipB regulates the multiple promoters in Escherichia coli.

Lin CY, Awano N, Masuda H, Park JH, Inouye M.

J Mol Microbiol Biotechnol. 2013;23(6):440-7. doi: 10.1159/000354311. Epub 2013 Sep 27.

26.

A case of multicentric castleman's disease of mixed-type, which showed constellation of symptoms, i.e., thrombocytopenia, anasarca, anemia, fever, myelofibrosis, and lymphadenopathy.

Awano N, Inomata M, Sonoda Y, Kondoh K, Ono R, Moriya A, Ando T, Kumasaka T, Takemura T, Takeuchi K, Ikushima S.

J Clin Exp Hematop. 2013;53(1):101-5. No abstract available.

27.

The protective effects of lactoferrin against murine norovirus infection through inhibition of both viral attachment and replication.

Ishikawa H, Awano N, Fukui T, Sasaki H, Kyuwa S.

Biochem Biophys Res Commun. 2013 May 17;434(4):791-6. doi: 10.1016/j.bbrc.2013.04.013. Epub 2013 Apr 17.

PMID:
23603257
28.

Mixed-type multicentric Castleman's disease developing during a 17-year follow-up of sarcoidosis.

Awano N, Inomata M, Kondoh K, Satake K, Kamiya H, Moriya A, Ando T, Kumasaka T, Takemura T, Takeuchi K, Ikushima S.

Intern Med. 2012;51(21):3061-6. Epub 2012 Nov 1. Review.

29.

Upper gastrointestinal sarcoidosis: report of three cases.

Inomata M, Ikushima S, Awano N, Kondoh K, Satake K, Masuo M, Moriya A, Kamiya H, Ando T, Azuma A, Takemura T.

Intern Med. 2012;51(13):1689-94. Epub 2012 Jul 1.

30.

Activation of COL1A2 promoter in human fibroblasts by Escherichia coli.

Miyazaki H, Kobayashi R, Ishikawa H, Awano N, Yamagoe S, Miyazaki Y, Matsumoto T.

FEMS Immunol Med Microbiol. 2012 Aug;65(3):481-7. doi: 10.1111/j.1574-695X.2012.00979.x. Epub 2012 May 18.

31.

YeeU enhances the bundling of cytoskeletal polymers of MreB and FtsZ, antagonizing the CbtA (YeeV) toxicity in Escherichia coli.

Masuda H, Tan Q, Awano N, Wu KP, Inouye M.

Mol Microbiol. 2012 Jun;84(5):979-89. doi: 10.1111/j.1365-2958.2012.08068.x. Epub 2012 May 17.

32.

A novel membrane-bound toxin for cell division, CptA (YgfX), inhibits polymerization of cytoskeleton proteins, FtsZ and MreB, in Escherichia coli.

Masuda H, Tan Q, Awano N, Yamaguchi Y, Inouye M.

FEMS Microbiol Lett. 2012 Mar;328(2):174-81. doi: 10.1111/j.1574-6968.2012.02496.x. Epub 2012 Jan 30.

33.

Successful treatment of ulcerative colitis associated with hypereosinophilic syndrome/chronic eosinophilic leukemia.

Awano N, Ryu T, Yoshimura N, Takazoe M, Kitamura S, Tanaka M.

Intern Med. 2011;50(16):1741-5. Epub 2011 Aug 15.

34.

YeeV is an Escherichia coli toxin that inhibits cell division by targeting the cytoskeleton proteins, FtsZ and MreB.

Tan Q, Awano N, Inouye M.

Mol Microbiol. 2011 Jan;79(1):109-18. doi: 10.1111/j.1365-2958.2010.07433.x. Epub 2010 Nov 5.

35.

Escherichia coli RNase R has dual activities, helicase and RNase.

Awano N, Rajagopal V, Arbing M, Patel S, Hunt J, Inouye M, Phadtare S.

J Bacteriol. 2010 Mar;192(5):1344-52. doi: 10.1128/JB.01368-09. Epub 2009 Dec 18.

36.

RNase activity of polynucleotide phosphorylase is critical at low temperature in Escherichia coli and is complemented by RNase II.

Awano N, Inouye M, Phadtare S.

J Bacteriol. 2008 Sep;190(17):5924-33. doi: 10.1128/JB.00500-08. Epub 2008 Jul 7.

37.

Complementation analysis of the cold-sensitive phenotype of the Escherichia coli csdA deletion strain.

Awano N, Xu C, Ke H, Inoue K, Inouye M, Phadtare S.

J Bacteriol. 2007 Aug;189(16):5808-15. Epub 2007 Jun 8.

38.

Effect of drug transporter genes on cysteine export and overproduction in Escherichia coli.

Yamada S, Awano N, Inubushi K, Maeda E, Nakamori S, Nishino K, Yamaguchi A, Takagi H.

Appl Environ Microbiol. 2006 Jul;72(7):4735-42.

39.

Functional analysis of L-serine O-acetyltransferase from Corynebacterium glutamicum.

Haitani Y, Awano N, Yamazaki M, Wada M, Nakamori S, Takagi H.

FEMS Microbiol Lett. 2006 Feb;255(1):156-63.

40.

Identification and functional analysis of Escherichia coli cysteine desulfhydrases.

Awano N, Wada M, Mori H, Nakamori S, Takagi H.

Appl Environ Microbiol. 2005 Jul;71(7):4149-52.

41.

Purification and characterization of O-Acetylserine sulfhydrylase of Corynebacterium glutamicum.

Wada M, Awano N, Yamazawa H, Takagi H, Nakamori S.

Biosci Biotechnol Biochem. 2004 Jul;68(7):1581-3.

42.

Effect of cysteine desulfhydrase gene disruption on L-cysteine overproduction in Escherichia coli.

Awano N, Wada M, Kohdoh A, Oikawa T, Takagi H, Nakamori S.

Appl Microbiol Biotechnol. 2003 Aug;62(2-3):239-43. Epub 2003 Mar 20.

PMID:
12883870
43.

Role of Saccharomyces cerevisiae serine O-acetyltransferase in cysteine biosynthesis.

Takagi H, Yoshioka K, Awano N, Nakamori S, Ono Bi.

FEMS Microbiol Lett. 2003 Jan 28;218(2):291-7.

44.
45.
46.

Detection of abnormal high-frequency components in the QRS complex by the wavelet transform in patients with idiopathic dilated cardiomyopathy.

Maehara K, Kokubun T, Awano N, Taira K, Ono M, Furukawa T, Shimizu Y, Maruyama Y.

Jpn Circ J. 1999 Jan;63(1):25-32.

47.

[Two cases of CA19-9 producing pulmonary papillary adenocarcinoma].

Hagiwara K, Sato K, Takahashi K, Shishido M, Awano N, Abe Y, Nagata K, Ohana N, Hoshino S.

Kyobu Geka. 1995 Oct;48(11):925-8. Japanese.

PMID:
7564016
48.

[Principles and applications of magnetocardiogram].

Awano N, Maruyama Y.

Nihon Rinsho. 1994 Jul;52 Suppl(Pt 1):741-5. Review. Japanese. No abstract available.

PMID:
12436610
49.

[Magnetocardiography using SQUID magnetometer].

Awano N, Kokubun T, Sakauchi Y, Maruyama Y, Kado H, Kasai N.

Nihon Rinsho. 1991 Aug;49(8):1927-39. Japanese. No abstract available.

PMID:
1787601
50.

[Assessment of myocardial viability by resting 201Tl SPECT image].

Owada K, Watanabe N, Kanbe M, Saitoh T, Asakura T, Awano N, Uchida T, Maruyama Y, Saitoh T, Katohno E, et al.

Kaku Igaku. 1990 Nov;27(11):1291-9. Japanese.

PMID:
2290197

Supplemental Content

Support Center